首页> 外文期刊>Urology >Evaluation of Patient-reported Quality-of-life Outcomes After Renal Surgery
【24h】

Evaluation of Patient-reported Quality-of-life Outcomes After Renal Surgery

机译:评估患者报告的肾脏手术后生活质量

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE:To assess the feasibility of 2 patient-reported health-related quality of life (HRQOL) instruments, Convalescence and Recovery Evaluation (CARE), and SF-12, as tools for evaluating HRQOL outcome consequences after renal surgery, and to determine which domains of these HRQOL instruments are most sensitive to HRQOL outcome effects of renal surgery.METHODS:Patients completed CARE and SF-12 preoperatively (baseline) and at 2, 4, 12, and 24 weeks after surgery. Clinical data, patient response rate, HRQOL changes over time, and likelihood of patient return to baseline HRQOL were evaluated. RESULTS:Seventy-one patients were enrolled. Sixty patients completed the baseline and at least 1 follow-up set of questionnaires. The CARE pain, gastrointestinal (GI), and activity domain scores and the SF-12 physical composite score (PCS) were sensitive to changes in HRQOL (all P<.05), whereas other domain subscores of these instruments did not change from presurgical baseline to postsurgical follow-up. Postsurgical HRQOL effects detected by the CARE pain, GI, and activity domains, and SF-12 PCS were most evident at 2 weeks (all P<.001). The CARE composite score demonstrated that 74% and 50% of patients returned to within 90% of baseline 4 weeks after radical and partial nephrectomy, respectively. CONCLUSION:Evaluation of patient-reported HRQOL outcomes after renal surgery is feasible; our findings suggest that the activity, pain, and GI domains of CARE and PCS subscores of the SF-12 are sensitive measures of HRQOL outcome consequences of renal surgery and represent appropriate measures of either care quality or comparative effectiveness analyses of robotic, laparoscopic, and open renal surgery.
机译:目的:评估两种患者报告的健康相关生活质量(HRQOL)仪器,康复和恢复评估(CARE)和SF-12作为评估肾手术后HRQOL结果后果的工具的可行性,并确定这些HRQOL仪器的领域对肾脏手术的HRQOL结局影响最敏感。方法:患者在术前以及术后2、4、12和24周完成了CARE和SF-12(基线)。评估临床数据,患者反应率,HRQOL随时间的变化以及患者恢复基线HRQOL的可能性。结果:71例患者入选。 60名患者完成了基线和至少1份后续调查表。 CARE疼痛,胃肠道(GI)和活动域得分以及SF-12身体综合得分(PCS)对HRQOL的变化敏感(所有P <.05),而这些器械的其他领域分值与术前相比没有变化术后随访的基线。通过CARE疼痛,胃肠道和活动区域以及SF-12 PCS检测到的术后HRQOL效果在2周时最为明显(所有P <.001)。 CARE综合评分显示,分别在根治性和部分肾切除术后4周,有74%和50%的患者恢复到基线的90%以内。结论:评估肾手术后患者报告的HRQOL结果是可行的;我们的研究结果表明,SF-12的CARE和PCS评分的活动,疼痛和GI域是肾脏手术HRQOL结果后果的敏感指标,代表了机器人,腹腔镜手术和机器人手术的护理质量或比较有效性分析的适当指标。开放性肾脏手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号